Natco Velpanat tablets:
Velpanat medication is actually a combination of sofosbuvir and velpatasvir. This drug is important when it comes to the reduction of Hepatitis C virus in the body of a patient who is suffering from this particular ailment. By this, the immune system of the patient fights against the infection and this restores the liver to normalcy. Velpanat Sofosbuvir and Velpatasvir that is in the quantity of 400mg and 100mg respectively in the Natco Velpanat tablets is used for tackling chronic hepatitis C or what we call as the long-lasting hepatitis C and there are times when this medicine is used with ribavirin that is another antiviral medication. The Hepatitis C is the viral infection that attacks the liver and can be dangerous for the human beings.
Common side effects of Velpanat Velpatasvir
Some of the common side effects include the feeling of headache that can increase and the patient also experiences the feeling of tiredness. The patient who uses this particular drug can also get an attack of nausea and diarrhoea. There can also be the problems related to sleep also called insomnia in the medical terms. When you take the doze of Velpanat velpatasvir+sofosbuvir and if you have the symptoms of slow heartbeats, it is advised to consult the doctor. If the shallow or weak breathing persists, it is advised to seek the consultation of a doctor. There could be the problems like the low red blood cells or the rapid heart rate or the weakness or the pale skin. In all such circumstances, it is advised to seek the advice of the doctor. There can also be a trouble in the concentration. All these need medical attention.
The launch of this drug in India at the affordable prices
Some time back, Natco Pharma launched the generic version of the drug by the name sofosbuvir in 400mg and velpatasvir 100mg that is in the fixed doze and the brand name of this drug is Natco Velpanat. All this was revealed by Natco pharma and this product is the generic version of the Epclusa tablets that are manufactured by the Gilead Sciences. The drug Velpanat is used for the treatment of adults who are suffering from chronic Hepatitis C genotype 1 to 6 with or without cirrhosis. The price kept by Natco pharma for this generic drug is much lower in India compared to the western nations. The company has signed the licensing agreement [non exclusive] with Gilead sciences for manufacturing and marketing of generic Epclusa.
Generic Epclusa, Velpanat price around $1000 to $1500 for 12 week treatment course.
The original new developed Hepatitis C drug price for the standard treatment is high and the total amount approximately $74760. This is actually unaffordable for maximum patients both from the developing as well as the developed nations. The Velpanat tablets which is a substitute and a mix of sofosbuvir and velpatasvir and the price for this generic drug falls down by 98 percent than the original medicine. You can say that the treatment cost is less and this is comparatively low for the patients.
The Natco Velpanat Velpatasvir has already hit the market.
It will not be wrong to say that Velpanat is the true copy of original Epclusa and this particular drug has got the same effectiveness as far as the treatment is concerned. Also when it comes to the side effects compared to the original, these are the same. So it is important to seek the consultancy of a reputed physician who is an expert in the treatment of Hepatitis C before the usage of this particular drug. India has the reputation of being the first nation of the world that makes generic drugs that are low in price but the effects of treatment are at par with the original.
Gilead sciences distributed licenses to make the generic versions to many Indian companies and also the pharmaceutical companies in various other third world countries.
Epclusa is a first developed medication for Hepatitis C that has the approval from FDA for all the genotypes 1,2,3,4,5 and 6. All these genotypes are covered by the same drug. Velpanat generally is used by the genotype 2 and 3 patients.
Velpanat Velpatasvir- Generic Epclusa in India
India is a leading country when it comes to the generic medicines. There were previous Hepatitis C medicines that were developed in India and one of them was generic Harvoni or the generic Sovaldi and these were initially developed in India. After getting the licenses from the Gilead sciences, many Indian drug manufacturers are even today in the process of manufacturing of the generic version of Epclusa. As per the originator, the licenses were given to the 12 manufacturing companies for the production of generic Epclusa. These are the same companies that were earlier provided the licenses for the manufacture of Sovaldi and Harvoni. The conclusion is generic versions have less price with same benefits. at Kahpro International you can get quality generic medicines at affordable price.
